Active Ingredient(s):Glimepiride + Rosiglitazone Maleate FDA Approved: * November 23, 2005 Pharm Company: *SB PHARMCO Category:Diabetes
Rosiglitazone (trade name Avandia) is an antidiabetic drug in the thiazolidinedione class. It works as an insulin sensitizer, by binding to the PPAR in fat cells and making the cells more responsive to insulin. It is marketed by the pharmaceutical company GlaxoSmithKline (GSK) as a stand-alone drug or for use in combination with metformin or with glimepiride. First released in 1999, annual sales peaked at approximately $2.5-billion in 2006; however, following a meta-analysis in 2007 that link...
* May have multiple approval dates, manufacturers, or labelers. 4 Discussions